User profiles for Adam de Havenon

Adam de Havenon

Yale University
Verified email at yale.edu
Cited by 9741

Large vessel occlusion stroke due to intracranial atherosclerotic disease: identification, medical and interventional treatment, and outcomes

A De Havenon, OO Zaidat, S Amin-Hanjani… - Stroke, 2023 - Am Heart Assoc
Large vessel occlusion stroke due to underlying intracranial atherosclerotic disease (ICAD-LVO)
is prevalent in 10 to 30% of LVOs depending on patient factors such as vascular risk …

Brain imaging with portable low-field MRI

…, R Bowry, SJ Schiff, A de Havenon… - Nature Reviews …, 2023 - nature.com
The advent of portable, low-field MRI (LF-MRI) heralds new opportunities in neuroimaging.
Low power requirements and transportability have enabled scanning outside the controlled …

Lacunar stroke: mechanisms and therapeutic implications

…, B Mac Grory, MSV Elkind, A de Havenon - Journal of Neurology …, 2021 - jnnp.bmj.com
Lacunar stroke is a marker of cerebral small vessel disease and accounts for up to 25% of
ischaemic stroke. In this narrative review, we provide an overview of potential lacunar stroke …

A prospective study of neurologic disorders in hospitalized patients with COVID-19 in New York City

…, J Torres, S Yaghi, K Ishida, E Scher, A De Havenon… - Neurology, 2021 - AAN Enterprises
Objective To determine the prevalence and associated mortality of well-defined neurologic
diagnoses among patients with coronavirus disease 2019 (COVID-19), we prospectively …

Multicontrast high-resolution vessel wall magnetic resonance imaging and its value in differentiating intracranial vasculopathic processes

M Mossa-Basha, WD Hwang, A De Havenon, D Hippe… - Stroke, 2015 - Am Heart Assoc
Background and Purpose— Although studies have attempted to differentiate intracranial
vascular disease using vessel wall magnetic resonance imaging (VWI), none have incorporated …

Direct oral anticoagulants versus warfarin in the treatment of cerebral venous thrombosis (ACTION-CVT): a multicenter international study

…, A Chang, S Cutting, H Xiao, A De Havenon… - Stroke, 2022 - Am Heart Assoc
Background: A small randomized controlled trial suggested that dabigatran may be as effective
as warfarin in the treatment of cerebral venous thrombosis (CVT). We aimed to compare …

Portable, low-field magnetic resonance imaging enables highly accessible and dynamic bedside evaluation of ischemic stroke

…, A Ward, J Schindler, L Sansing, A de Havenon… - Science …, 2022 - science.org
Brain imaging is essential to the clinical management of patients with ischemic stroke. Timely
and accessible neuroimaging, however, can be limited in clinical stroke pathways. Here, …

Endovascular therapy of anterior circulation tandem occlusions: pooled analysis from the TITAN and ETIS registries

…, R Bourcier, M Kyheng, J Labreuche, A de Havenon… - Stroke, 2021 - Am Heart Assoc
Background and Purpose: Endovascular therapy for tandem occlusion strokes of the anterior
circulation is an effective and safe treatment. The best treatment approach for the cervical …

Blood pressure after endovascular thrombectomy and outcomes in patients with acute ischemic stroke: an individual patient data meta-analysis

…, B Van Adel, AM Spiotta, EC Sandset, A de Havenon… - Neurology, 2022 - AAN Enterprises
Background and Objectives To explore the association between blood pressure (BP) levels
after endovascular thrombectomy (EVT) and the clinical outcomes of patients with acute …

Results from DEFUSE 3: good collaterals are associated with reduced ischemic core growth but not neurologic outcome

A de Havenon, M Mlynash, MA Kim-Tenser… - Stroke, 2019 - Am Heart Assoc
Background and Purpose— The effect of leptomeningeal collaterals for acute ischemic stroke
patients with large vessel occlusion in the late window (>6 hours from last known normal) …